Thanks to a new partnership with Quest Diagnostics.
IBM Watson is teaming up with Quest Diagnostics in a significant expansion of its ongoing cancer genomic sequencing and precision medicine push.
The company announced Monday it is launching a new service with lab testing giant Quest and New York’s Memorial Sloan Kettering Cancer Center called Watson Genomics from Quest Diagnostics. “The service will make Watson for Genomics widely available to physician and patients nationwide for the first time,” said IBM in a statement.
